Literature DB >> 11764067

Current status of HER2 testing: caught between a rock and a hard place.

S J Schnitt1, T W Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11764067     DOI： 10.1309/WMN8-VTR5-DUGF-X12L

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  10 in total

1.  Integrating molecular diagnostics into anticancer drug discovery.

Authors:  István Peták; Richárd Schwab; László Orfi; László Kopper; György Kéri
Journal:  Nat Rev Drug Discov       Date:  2010-06-07       Impact factor: 84.694

2.  Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system.

Authors:  Rachel Stevens; Imad Almanaseer; Miguel Gonzalez; Derin Caglar; Ryan A Knudson; Rhett P Ketterling; Daniel S Schrock; Thomas A Seemayer; Julia A Bridge
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

3.  Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assessment in breast cancer.

Authors:  Cornelia Hauser-Kronberger; Nadia Dandachi
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

4.  A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2.

Authors:  Kristian Jensen; Rikke Krusenstjerna-Hafstrøm; Jesper Lohse; Kenneth H Petersen; Helene Derand
Journal:  Mod Pathol       Date:  2016-10-21       Impact factor: 7.842

5.  Optical fiber-based in vivo quantification of growth factor receptors.

Authors:  Thommey P Thomas; Yu-Chung Chang; Jing Yong Ye; Alina Kotlyar; Zhengyi Cao; Rameshwer Shukla; Suyang Qin; Theodore B Norris; James R Baker
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

6.  Molecular mechanisms of antigen retrieval: antigen retrieval reverses steric interference caused by formalin-induced cross-links.

Authors:  S A Bogen; K Vani; S R Sompuram
Journal:  Biotech Histochem       Date:  2009-10       Impact factor: 1.718

7.  Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arrays.

Authors:  Maziar Assadi; Jens Lamerz; Tiantom Jarutat; Alexandra Farfsing; Hubert Paul; Berthold Gierke; Ewa Breitinger; Markus F Templin; Laurent Essioux; Susanne Arbogast; Miro Venturi; Michael Pawlak; Hanno Langen; Thomas Schindler
Journal:  Mol Cell Proteomics       Date:  2013-05-07       Impact factor: 5.911

8.  Concomitant detection of HER2 protein and gene alterations by immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) identifies HER2 positive breast cancer with and without gene amplification.

Authors:  Zsuzsanna Varga; Raymond R Tubbs; Holger Moch
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

9.  Correlation of Immunohistochemistry and Fluorescence in Situ Hybridization for HER-2 Assessment in Breast Cancer Patients: Single Centre Experience.

Authors:  Magdalena Bogdanovska-Todorovska; Slavica Kostadinova-Kunovska; Rubens Jovanovik; Blagica Krsteska; Goran Kondov; Borislav Kondov; Gordana Petrushevska
Journal:  Open Access Maced J Med Sci       Date:  2018-03-23

10.  Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study.

Authors:  Zsuzsanna Varga; Aurelia Noske; Constanze Ramach; Barbara Padberg; Holger Moch
Journal:  BMC Cancer       Date:  2013-12-30       Impact factor: 4.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.